Pang Long, Shen Shaofei, Ma Chao, Ma Tongtong, Zhang Rui, Tian Chang, Zhao Lei, Liu Wenming, Wang Jinyi
Colleges of Veterinary Medicine and Science, Northwest A&F University, Yangling, Shaanxi 712100, P. R. China.
Analyst. 2015 Nov 7;140(21):7335-46. doi: 10.1039/c5an00799b.
Cell sorting by filtration techniques offers a label-free approach for cell separation on the basis of size and deformability. However, filtration is always limited by the unpredictable variation of the filter hydrodynamic resistance due to cell accumulation and clogging in the microstructures. In this study, we present a new integrated microfluidic device for cell separation based on the cell size and deformability by combining the microstructure-constricted filtration and pneumatic microvalves. Using this device, the cell populations sorted by the microstructures can be easily released in real time for subsequent analysis. Moreover, the periodical sort and release of cells greatly avoided cell accumulation and clogging and improved the selectivity. Separation of cancer cells (MCF-7, MDA-MB-231 and MDA231-LM2) with different deformability showed that the mixture of the less flexible cells (MCF-7) and the flexible cells (MDA-MB-231 and MDA231-LM2) can be well separated with more than 75% purity. Moreover, the device can be used to separate cancer cells from the blood samples with more than 90% cell recovery and more than 80% purity. Compared with the current filtration methods, the device provides a new approach for cancer cell separation with high collection recovery and purity, and also, possesses practical potential to be applied as a sample preparation platform for fundamental studies and clinical applications.
通过过滤技术进行细胞分选提供了一种基于大小和可变形性的无标记细胞分离方法。然而,由于细胞在微结构中的积累和堵塞,过滤总是受到过滤器流体动力阻力不可预测变化的限制。在本研究中,我们通过结合微结构受限过滤和气动微阀,提出了一种基于细胞大小和可变形性的新型集成微流控细胞分离装置。使用该装置,通过微结构分选的细胞群体可以很容易地实时释放,以便进行后续分析。此外,细胞的周期性分选和释放极大地避免了细胞积累和堵塞,并提高了选择性。对具有不同可变形性的癌细胞(MCF-7、MDA-MB-231和MDA231-LM2)进行分离表明,刚性较低的细胞(MCF-7)与柔性细胞(MDA-MB-231和MDA231-LM2)的混合物能够以超过75%的纯度得到良好分离。此外,该装置可用于从血液样本中分离癌细胞,细胞回收率超过90%,纯度超过80%。与目前的过滤方法相比,该装置为癌细胞分离提供了一种具有高收集回收率和纯度的新方法,并且具有作为基础研究和临床应用的样品制备平台的实际潜力。